
New analysis introduced on the 2025 Annual Scientific Assembly of the American Faculty of Allergy, Bronchial asthma and Immunology (ACAAI) presents encouraging information for fogeys of younger youngsters with peanut allergy symptoms. An extended-term examine discovered {that a} peanut patch remedy—epicutaneous immunotherapy—continued to assist toddlers safely construct tolerance to peanuts over three years.
The analysis was additionally printed within the Annals of Allergy Bronchial asthma & Immunology.
The remedy, generally known as the Viaskin Peanut Patch, delivers small quantities of peanut protein by means of the pores and skin. The objective is to coach the immune system to tolerate peanut publicity and cut back the chance of extreme allergic reactions from unintentional ingestion.
This new evaluation checked out toddlers who initially obtained placebo in an earlier one-year examine after which used the peanut patch for as much as three years. After three years of remedy, greater than 70% of those youngsters might tolerate the equal of a minimum of three to 4 peanut kernels—a big enchancment from their first yr of remedy. Practically half might tolerate even increased quantities.
Importantly, the remedy continued to indicate a robust security report. No instances of treatment-related anaphylaxis (a extreme allergic response) had been reported within the third yr. Pores and skin irritation on the patch web site—the commonest aspect impact—turned much less frequent over time. Researchers additionally discovered that youngsters’s reactions throughout meals challenges turned milder, with fewer extreme signs after three years than after one yr.
“These outcomes present that ongoing remedy with the peanut patch continues to enhance tolerance and stays secure over time,” mentioned allergist Matthew Greenhawt, MD, MBA, lead creator and ACAAI member.
“For folks of toddlers with peanut allergies, this sort of strategy could someday supply peace of thoughts by lowering the chance of getting an allergic response, together with extreme reactions, from unintentional publicity.”
Peanut allergy impacts about 2% of youngsters within the U.S. and is a number one explanation for extreme allergic reactions. The examine outcomes add to rising proof that early intervention in young children might assist change the course of peanut allergy.
Researchers stress that oldsters mustn’t try any type of peanut desensitization at dwelling and may focus on rising treatment options with a board-certified allergist.
Extra data:
M. Greenhawt, et al. LONG-TERM EFFICACY AND SAFETY OF EPICUTANEOUS IMMUNOTHERAPY IN PEANUT-ALLERGIC TODDLERS: EPOPEX END OF STUDY RESULTS, Annals of Allergy Bronchial asthma & Immunology (2025).
Quotation:
Peanut patch remedy continues to assist toddlers safely construct tolerance over three years (2025, November 6)
retrieved 6 November 2025
from https://medicalxpress.com/information/2025-11-peanut-patch-treatment-toddlers-safely.html
This doc is topic to copyright. Other than any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.
Trending Merchandise
The Pout-Pout Fish
Giraffes Can’t Dance
Moo, Baa, La La La!
Manhattan Toy Skwish Color Burst Rattle ...
Doggies
